<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00564694</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000574769</org_study_id>
    <secondary_id>EORTC-QLQ-CR29</secondary_id>
    <secondary_id>EU-20783</secondary_id>
    <nct_id>NCT00564694</nct_id>
  </id_info>
  <brief_title>Studying a Quality of Life Questionnaire in Patients With Colorectal Cancer</brief_title>
  <official_title>Validation of an EORTC Quality of Life Questionnaire Module for Patients With Colorectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Collecting information about the quality of life of patients with colorectal
      cancer may help doctors learn more about the disease.

      PURPOSE: This clinical trial is studying the European Organization of Research for the
      Treatment of Cancer (EORTC) quality-of-life-questionnaire in patients with colorectal cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        -  To test the reliability and clinical and psychometric validity of the European
           Organization of Research for the Treatment of Cancer (EORTC) quality of life
           questionnaire (QLQ-CR29) in an international sample of patients with colorectal cancer.

      OUTLINE: This is a multicenter study. Patients are stratified into predetermined clinically
      distinct groups (colon cancer after surgery vs colon cancer undergoing adjuvant chemotherapy
      vs rectal cancer undergoing neoadjuvant radiotherapy vs rectal cancer after anterior
      resection with temporary stoma vs rectal cancer after abdominoperineal excision of rectum vs
      colorectal cancer undergoing palliative chemotherapy).

      Quality-of-life data is collected alongside standard outcomes in patients undergoing
      treatment for colorectal cancer. Patients complete the European Organization of Research for
      the Treatment of Cancer (EORTC) quality of life questionnaire (QLQ-C30), the revised
      colorectal cancer module (QLQ-CR29), case report forms for clinical and sociodemographic
      data, and a debriefing questionnaire at different time points before, during, and after
      treatment. Some patients complete more sets of the same questionnaire at later time points to
      assess sensitivity to change over time and test-retest reliability. Reliability, and clinical
      and psychometric validity of the questionnaires are assessed by correlation analyses,
      exploration of known group comparisons, and responsiveness to clinical changes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Reliability and clinical and psychometric validity of the European Organization of Research for the Treatment of Cancer (EORTC) quality of life questionnaire (QLQ-CR29)</measure>
  </primary_outcome>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Colorectal Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>psychosocial assessment and care</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>quality-of-life assessment</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Histologically confirmed adenocarcinoma of the colon or rectum

          -  No brain metastases or intracranial tumor extension with cognitive impairment

        PATIENT CHARACTERISTICS:

          -  No limit on performance status

          -  Able to understand the language of the questionnaire

          -  No psychological, familial, sociological, or geographical condition potentially
             hampering compliance with the study protocol and follow-up schedule

          -  No other concurrent malignancies except basal cell carcinoma of the skin

        PRIOR CONCURRENT THERAPY:

          -  No prior participation in this study (in a different subgroup)

          -  No concurrent participation in other quality of life studies that might interfere with
             this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jane Blazeby, MB, CHB, FRCS, BSc, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospitals Bristol NHS Foundation Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Alexis Vautrin</name>
      <address>
        <city>Vandoeuvre-les-Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite University Medical Center of Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>D-13347</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universitaet Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>D-93053</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Basingstoke and North Hampshire NHS Foundation Trust</name>
      <address>
        <city>Basingstoke</city>
        <state>England</state>
        <zip>RG24 9NA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bristol Haematology and Oncology Centre</name>
      <address>
        <city>Bristol</city>
        <state>England</state>
        <zip>BS2 8ED</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Arraras JI, Suárez J, Arias de la Vega F, Vera R, Asín G, Arrazubi V, Rico M, Teijeira L, Azparren J. The EORTC Quality of Life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients. Clin Transl Oncol. 2011 Jan;13(1):50-6. doi: 10.1007/s12094-011-0616-y.</citation>
    <PMID>21239355</PMID>
  </results_reference>
  <results_reference>
    <citation>Nowak W, Tobiasz-Adamczyk B, Brzyski P, Sałówka J, Kuliś D, Richter P. Adaptation of quality of life module EORTC QLQ-CR29 for Polish patients with rectal cancer: initial assessment of validity and reliability. Pol Przegl Chir. 2011 Sep;83(9):502-10. doi: 10.2478/v10035-011-0078-5.</citation>
    <PMID>22166739</PMID>
  </results_reference>
  <results_reference>
    <citation>Whistance RN, Conroy T, Chie W, Costantini A, Sezer O, Koller M, Johnson CD, Pilkington SA, Arraras J, Ben-Josef E, Pullyblank AM, Fayers P, Blazeby JM; European Organisation for the Research and Treatment of Cancer Quality of Life Group. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer. 2009 Nov;45(17):3017-26. doi: 10.1016/j.ejca.2009.08.014. Epub 2009 Sep 16.</citation>
    <PMID>19765978</PMID>
  </results_reference>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2007</study_first_submitted>
  <study_first_submitted_qc>November 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 28, 2007</study_first_posted>
  <last_update_submitted>October 28, 2013</last_update_submitted>
  <last_update_submitted_qc>October 28, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2013</last_update_posted>
  <keyword>adenocarcinoma of the colon</keyword>
  <keyword>recurrent colon cancer</keyword>
  <keyword>stage I colon cancer</keyword>
  <keyword>stage II colon cancer</keyword>
  <keyword>stage III colon cancer</keyword>
  <keyword>stage IV colon cancer</keyword>
  <keyword>adenocarcinoma of the rectum</keyword>
  <keyword>recurrent rectal cancer</keyword>
  <keyword>stage I rectal cancer</keyword>
  <keyword>stage II rectal cancer</keyword>
  <keyword>stage III rectal cancer</keyword>
  <keyword>stage IV rectal cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

